A woman who used Wegovy and Ozempic says the drugmaker didn't adequately warn her, or other patients, of serious side effects ...

Like before, Instagram recommends using JPEG and PNG file formats for photos and MP4 ... An example is Henry Meds posting Reels for its semaglutide online products. In this example, the messaging is ...

The FDA, through its 503B program, authorizes compounding pharmacies to make non-generic drugs that are listed in shortage, such as semaglutide currently. But watching this space evolve ...

Some plans include clinical options like prescription drugs. Over the years, options like Semaglutide and Tirzepatide have shown promising results in clinical trials, and Czarina has witnessed ...

While sparse data makes accurate measurement difficult, most would agree violence and lawlessness are increasing in many parts of PNG. The broader context for this violence includes: rural decay ...

After a regulatory hiccup earlier this month, Novo Nordisk’s heart failure ambitions for its obesity star Wegovy (semaglutide) are starting to get back on track. Novo’s semaglutide cut the ...

Weight loss drugs made with so-called GLP-1 analogs like semaglutide—including Ozempic, Wegovy and Mounjaro—were not found to be associated with an increased risk of depression, suicidal ...

Doctors have called GLP-1 medications — including semaglutide brand names Ozempic and Wegovy — “miracle drugs” for weight loss, offering a potential solution to Tennessee’s obesity ...

According to a study published today in Annals of Internal Medicine, expanding Medicare coverage for semaglutide could make millions of older Americans newly eligible for the drug, but with the ...

If you haven’t heard of semaglutide yet, there’s a lot to know about this medicine making waves in the world of health and wellness. Originally designed for type 2 diabetes, this medication is ...

Around one in seven Medicare beneficiaries with a high body mass index (BMI) may be newly eligible for semaglutide treatment after Medicare allowed Part D plans to cover the drug for patients with ...